DHG Pharmaceutical JSC (HOSE: DHG)

Vietnam flag Vietnam · Delayed Price · Currency is VND
99,700
0.00 (0.00%)
At close: Nov 20, 2024
-4.23%
Market Cap 13.02T
Revenue (ttm) 4.96T
Net Income (ttm) 804.09B
Shares Out 130.75M
EPS (ttm) 6,149.98
PE Ratio 16.20
Forward PE 12.95
Dividend 7,500.00 (7.52%)
Ex-Dividend Date Aug 8, 2024
Volume 9,400
Open 100,000
Previous Close 99,700
Day's Range 99,000 - 100,000
52-Week Range 95,000 - 125,900
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 20, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products primarily in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health supplements and pharmaceuticals cosmeceuticals. It also exports its products to Moldova, Ukraine, Romania, Myanmar, Russi... [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 2,789
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DHG
Full Company Profile

Financial Performance

In 2023, DHG Pharmaceutical JSC's revenue was 5.02 trillion, an increase of 7.26% compared to the previous year's 4.68 trillion. Earnings were 1.02 trillion, an increase of 6.31%.

Financial Statements

News

There is no news available yet.